LOS ANGELES—Edelman has added the California Institute for Regenerative Medicine, Genitope Corporation, Ikaria, and Tercica to its growing life sciences practice. Edelman now represents more than 45 life sciences companies.
To provide leadership to the practice, the firm also named Lorie Fiber as executive vice president and director of U.S. development for life sciences, is a new position within the firm that reflects its commitment to the health sector and its belief in the future growth of healthcare and life sciences industry.
Fiber will spearhead the firm’s life sciences growth in partnership with colleagues in Los Angeles, San Francisco, New York, Dallas, Chicago, Washington and Seattle, where deputy GM and EVP Rose Berg-Fosnaugh has developed a life sciences practice with clients such as Fred Hutchinson Cancer Research Center and Ikaria.
“Edelman’s convergence approach, which brings together specialists from across the firm, has been instrumental for several years in attracting and serving companies with complex businesses and ambitious goals,” said Pam Talbot, president and chief executive officer, Edelman U.S. “Our ability to bring together the best talent from across our global network has directly led to the expansion of this practice area.”
Life sciences clients can draw on a blend of health and biomedical capabilities as well as financial, media, interactive and editorial talent at any point along their growth curve or product life cycle.
Edelman also has hired Courtney Walker as vice president and Brendan Doherty as senior account supervisor in the New York and San Francisco offices respectively.